100 filings
Page 2 of 5
8-K
801xm2h4c4jo0m9lvwx
9 Nov 22
Cost Associated with Exit or Disposal Activities
8:30am
8-K
2d4d l2i8zrvwd8fwn
2 Nov 22
Surgalign Announces Third Quarter 2022 Results and Provides Update on Business Operations and Financial Outlook
4:06pm
8-K
b4s9stpad wp6m5r
24 Aug 22
Surgalign Announces FDA 510(k) Clearance of the CorteraTM Spinal Fixation System – The Company’s New Flagship Posterior Fixation Platform
4:41pm
8-K
b0icsfv32o yxmsv
10 Aug 22
Surgalign Announces Global Settlement Agreement with Parties enter into new sole-source supply relationship, extended for two years
5:02pm
8-K
inzm5t olrwfes
9 Aug 22
Surgalign Holdings, Inc. Announces Second Quarter 2022 Results and Reiterates Full Year 2022 Revenue Guidance Range
12:00am
8-K
9of4eyw02omwk 0riy
4 Aug 22
Surgalign Reaches Settlement with the Securities and Exchange Commission
5:38pm
8-K
n2w1czfu
2 Jun 22
Other Events
1:00pm
8-K
r7i7armwuqo14sr
16 May 22
Surgalign Holdings, Inc. Announces 1-for-30 Reverse Stock Split
6:06am
8-K
y6wsfppzpvz
12 May 22
Submission of Matters to a Vote of Security Holders
3:52pm
8-K
khxm6f
10 May 22
Surgalign Holdings, Inc. Announces First Quarter 2022 Results and Raises Full Year 2022 Revenue Guidance Range
4:11pm
8-K
a2jm6gl
7 Apr 22
Departure of Directors or Certain Officers
4:06pm
8-K/A
fzpmt
18 Mar 22
Financial Statements and Exhibits
7:04am
8-K
f6jq xzmnarpp8s5od
15 Mar 22
Surgalign Holdings, Inc. Announces Fourth Quarter and Full Year 2021 Results
4:04pm
8-K
5l4t55gc3m hhrs0e
7 Mar 22
Surgalign Announces Appointment of David Lyle as Chief Financial Officer
9:07am
8-K
b41wn emr
15 Feb 22
Entry into a Material Definitive Agreement
4:06pm
8-K
qk6y8olqhsgc1pc2
27 Jan 22
Regulation FD Disclosure
8:57am
8-K
4o0lp3e0m 9g4
18 Jan 22
Results of Operations and Financial Condition
7:15am
8-K
khmsjna
5 Jan 22
Entry into a Material Definitive Agreement
4:10pm
8-K
8rzhl
27 Dec 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:15pm
8-K
lt2vz aymk8
17 Dec 21
Other Events
9:13am